Corvus Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CRVS Nasdaq 2834 www.corvuspharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Corvus Pharmaceuticals, Inc.

Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026 - Feb 2nd, 2026 8:39 am
Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why - Jan 27th, 2026 10:15 am
Corvus Pharmaceuticals (CRVS) Is Up 211.80% in One Week: What You Should Know - Jan 27th, 2026 10:00 am
Wall Street Analysts Think Corvus (CRVS) Could Surge 25.29%: Read This Before Placing a Bet - Jan 27th, 2026 7:55 am
Corvus Pharmaceuticals (CRVS) Falls on Profit-Taking After 212% Jump - Jan 27th, 2026 3:03 am
Corvus Pharmaceuticals (CRVS) Soars 212% on Impressive Eczema Therapy Study - Jan 25th, 2026 5:47 pm
Why Corvus Pharmaceuticals (CRVS) Is Up 211.8% After Upsized Equity Raise On Soquelitinib Phase 2 Plans - Jan 24th, 2026 1:09 pm
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M - Jan 23rd, 2026 3:00 pm
Corvus Pharmaceuticals (CRVS) Hits All-Time High on Eczema Trial Results - Jan 23rd, 2026 6:11 am
Corvus Pharmaceuticals Shares New Phase I Soquelitinib Data Showing Strong AD EASI Gains - Jan 23rd, 2026 1:01 am
Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - Jan 21st, 2026 8:53 pm
Corvus shares nearly triple on positive data for eczema pill - Jan 21st, 2026 4:39 am
Assessing Corvus Pharmaceuticals (CRVS) Valuation After Positive Soquelitinib Phase 1 Atopic Dermatitis Data - Jan 20th, 2026 7:16 pm
Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data - Jan 20th, 2026 4:17 pm
Why Small Biotech Stock Corvus Pharma Just Launched To A Nine-Year High - Jan 20th, 2026 2:07 pm
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Jan 20th, 2026 2:01 pm
Top Midday: Stocks Fall on Heightened Trade War Fears; Netflix, Warner Bros. Amend Agreement to All-Cash Deal - Jan 20th, 2026 9:28 am
BC-Most Active Stocks - Jan 20th, 2026 8:30 am
Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis - Jan 20th, 2026 5:00 am
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis - Jan 16th, 2026 2:01 pm